Literature DB >> 25079040

Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet.

Mitra Zarrati1, Eisa Salehi, Keramat Nourijelyani, Vahid Mofid, Mohammad Javad Hossein Zadeh, Forouzan Najafi, Zahra Ghaflati, Katayoon Bidad, Maryam Chamari, Mehrdad Karimi, Farzad Shidfar.   

Abstract

OBJECTIVES: The purpose of this study was to investigate whether probiotics had an effect on proinflammatory markers and cytokines in overweight and obese individuals and whether they could have synergistic effects with weight-loss diets.
METHODS: A total of 75 healthy overweight and obese individuals completed this randomized doubled-blind controlled clinical trial. Participants were randomly assigned to groups consuming regular yogurt with a low-calorie diet (LCD, RLCD; n = 25) or receiving probiotic yogurt with LCD (PLCD; n = 25) or consuming probiotic yogurt without LCD (PWLCD; n = 25) for 8 weeks. The pribiotic regimen contained 200 g/day yogurt, enriched by Lactobacillus acidophilus La5, Bifidobacterium BB12, and Lactobacillus casei DN001 10(8) colony-forming units/g. Body fat percentage, high-sensitive C-reactive protein (hs-CRP), tumor necrosis factor-alpha (TNF-α), leptin, and mRNA levels of inflammation-related genes (TNF-α and RAR-related orphan receptor gamma [ROR-γt]) in peripheral blood mononuclear cells (PBMCs) were measured.
RESULTS: A reduction in body mass index (BMI), fat percentage, and leptin level was observed that was more obvious in groups who received the weight-loss diet with probiotic yogurt. Reduction in the gene expression of ROR-γt was significant in the PLCD group (p < 0.001). The expression of TNF-α did not change among all groups after intervention. The mean concentration of leptin was significantly decreased in all groups after the dietary intervention, but the mean changes in leptin level in the PLCD group was more prominent compared to the other two groups (-2.38, p < 0.001 [PLCD] vs -1.75, p = 0.002 [RLCD] and -0.55 ng/mL, p = 0.12 [PWLCD]). The reduction in serum levels of hs-CRP was more evident in the PWLCD group compared to the PLCD and RLCD groups after the 8-week intervention (-3.4, p = 0.03 vs -1.76, p < 0.001 and -2.98 pg/mL, p < 0.001, respectively).
CONCLUSION: Our results suggested that the weight-loss diet and probiotic yogurt had synergistic effects on T-cells subset specific gene expression in PBMCs, fat percentage, and body weight among overweight and obese individuals.

Entities:  

Keywords:  PBMCs; hs-CRP; leptin; obesity; probiotics

Mesh:

Substances:

Year:  2014        PMID: 25079040     DOI: 10.1080/07315724.2013.874937

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  33 in total

1.  The role of gut micorbiome in obesity and diabetes.

Authors:  Katarzyna Górowska-Kowolik; Agata Chobot
Journal:  World J Pediatr       Date:  2019-05-27       Impact factor: 2.764

Review 2.  Effect of Yogurt Consumption on Metabolic Syndrome Risk Factors: a Narrative Review.

Authors:  Leila Khorraminezhad; Iwona Rudkowska
Journal:  Curr Nutr Rep       Date:  2021-01-06

3.  Effects of Probiotic Yogurt on Serum Omentin-1, Adropin, and Nesfatin-1 Concentrations in Overweight and Obese Participants Under Low-Calorie Diet.

Authors:  Mitra Zarrati; Mahsa Raji Lahiji; Eisa Salehi; Bahareh Yazdani; Elham Razmpoosh; Raheleh Shokouhi Shoormasti; Farzad Shidfar
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

4.  Fermented Dairy Products, Probiotic Supplementation, and Cardiometabolic Diseases: A Systematic Review and Meta-analysis.

Authors:  Judit Companys; Laura Pla-Pagà; Lorena Calderón-Pérez; Elisabet Llauradó; Rosa Solà; Anna Pedret; Rosa M Valls
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

5.  Clostridium butyricum Supernatant Regulates the Expression of RORγt in HCT-116 Cells by Inhibiting the TLR2/MyD88/NF-κB Signaling Pathway.

Authors:  Ying Xie; Linyan Zhou; Hui Li; Yan Li
Journal:  Curr Microbiol       Date:  2021-03-06       Impact factor: 2.188

6.  Milk and Dairy Product Consumption and Inflammatory Biomarkers: An Updated Systematic Review of Randomized Clinical Trials.

Authors:  Stine M Ulven; Kirsten B Holven; Angel Gil; Oscar D Rangel-Huerta
Journal:  Adv Nutr       Date:  2019-05-01       Impact factor: 8.701

Review 7.  Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes.

Authors:  Christy B Williamson; Cathleen M Burns; Crystal M Gossard; Jessica M Pizano; Keren E Dolan; Heather J Finley; Margaret G Gasta; Emily C Parker; Elizabeth A Lipski
Journal:  Integr Med (Encinitas)       Date:  2017-02

8.  The Relationship between Serum Oxalic Acid, Central Hemodynamic Parameters and Colonization by Oxalobacter formigenes in Hemodialysis Patients.

Authors:  Baris Gulhan; Kultigin Turkmen; Merve Aydin; Murat Gunay; Aytekin Cıkman; Murat Kara
Journal:  Cardiorenal Med       Date:  2015-04-17       Impact factor: 2.041

9.  Probiotic Soy Milk Consumption and Renal Function Among Type 2 Diabetic Patients with Nephropathy: a Randomized Controlled Clinical Trial.

Authors:  Maryam Miraghajani; Nafiseh Zaghian; Abolfazl Dehkohneh; Maryam Mirlohi; Reza Ghiasvand
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

10.  Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease.

Authors:  John P Haran; Beth A McCormick
Journal:  Gastroenterology       Date:  2020-12-08       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.